286 related articles for article (PubMed ID: 29030659)
1. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
Sun Y; Ma L; Ma L; Kong X; Chen H; Lv P; Lin J; Liu H; Yan Y; Ji Z; Yang C; Dai S; Wan W; Zou Y; Jin X; Jiang L
Rheumatol Int; 2017 Dec; 37(12):2019-2026. PubMed ID: 29030659
[TBL] [Abstract][Full Text] [Related]
2. Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu's arteritis.
Sun Y; Ma L; Ji Z; Zhang Z; Chen H; Liu H; Shan Y; Yan F; Jiang L
Clin Rheumatol; 2016 Mar; 35(3):685-93. PubMed ID: 25665823
[TBL] [Abstract][Full Text] [Related]
3. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
4. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
[TBL] [Abstract][Full Text] [Related]
5. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate.
Ozen S; Duzova A; Bakkaloglu A; Bilginer Y; Cil BE; Demircin M; Davin JC; Bakkaloğlu M
J Pediatr; 2007 Jan; 150(1):72-6. PubMed ID: 17188618
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.
Park MC; Lee SW; Park YB; Chung NS; Lee SK
Scand J Rheumatol; 2005; 34(4):284-92. PubMed ID: 16195161
[TBL] [Abstract][Full Text] [Related]
7. Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate.
Mevorach D; Leibowitz G; Brezis M; Raz E
Ann Rheum Dis; 1992 Jul; 51(7):904-5. PubMed ID: 1352962
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
9. Low-dose methotrexate as a steroid-sparing agent in a child with Takayasu's arteritis.
Shetty AK; Stopa AR; Gedalia A
Clin Exp Rheumatol; 1998; 16(3):335-6. PubMed ID: 9631760
[TBL] [Abstract][Full Text] [Related]
10. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
11. The management of Takayasu's arteritis: personal experience.
de Franciscis S; Serra R; Luongo A; Sabino G; Puzziello A
Ann Vasc Surg; 2007 Nov; 21(6):754-60. PubMed ID: 17512164
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
Kong X; Zhang X; Lv P; Cui X; Ma L; Chen H; Liu H; Lin J; Jiang L
Int J Cardiol; 2018 Sep; 266():222-228. PubMed ID: 29729868
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in Takayasu's arteritis.
Goel R; Danda D; Mathew J; Edwin N
Clin Rheumatol; 2010 Mar; 29(3):329-32. PubMed ID: 20054700
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT.
Henes JC; Mueller M; Pfannenberg C; Kanz L; Kötter I
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S43-8. PubMed ID: 21385544
[TBL] [Abstract][Full Text] [Related]
15. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu's arteritis.
John RA; Keshava SN; Danda D
Int J Rheum Dis; 2017 Jul; 20(7):882-886. PubMed ID: 28736969
[TBL] [Abstract][Full Text] [Related]
16. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate.
Hoffman GS; Leavitt RY; Kerr GS; Rottem M; Sneller MC; Fauci AS
Arthritis Rheum; 1994 Apr; 37(4):578-82. PubMed ID: 7908520
[TBL] [Abstract][Full Text] [Related]
17. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort.
Cui X; Dai X; Ma L; Yang C; Tan W; Zhang L; Zhang Z; Feng X; Wu R; Zou Y; Zhou Z; Lu Y; Wang Y; Wu M; Li S; Wang L; Lin H; Dong Z; Fu W; Sun X; Wang C; Ding J; Lv P; Lin J; Jiang L;
Semin Arthritis Rheum; 2020 Feb; 50(1):59-65. PubMed ID: 31350057
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
